RSO in Maine 2026: A Buyer's Guide to Rick Simpson Oil

What RSO Actually Is

RSO is a full-spectrum cannabis oil produced by washing decarboxylated cannabis flower in food-grade ethanol, filtering out the plant material, and evaporating the ethanol to leave a thick, dark, cannabis-saturated oil. The process is mechanically simple but the result is chemically distinct from the other concentrate categories on a Maine dispensary shelf.

The Production Process

The starting material is high-quality cannabis flower that has been decarboxylated — heated to convert the THCA and CBDA into the active THC and CBD forms. The decarbed flower is submerged in food-grade ethanol (typically 190-proof or higher), agitated to dissolve the cannabinoids and terpenes, and then filtered to remove the plant material. The ethanol is evaporated, typically under low heat and sometimes under vacuum, to leave a thick dark oil. The final product is a viscous, dark brown to black substance with a strong cannabis aroma and a THC content of 50-80%.

Full-Spectrum vs. Distillate

The ethanol wash is a non-selective solvent. It pulls THC, CBD, CBG, CBN, CBC, THCV, the native terpenes, flavonoids, and the plant waxes. The result is a chemically complex oil that preserves the full cannabinoid and terpene profile of the source flower. This is the defining feature of RSO and the source of the "entourage effect" argument — the theory that the full chemical profile of the plant works synergistically in ways that isolated THC does not.

Distillate, by contrast, is the product of short-path or wiped-film distillation, a process that strips almost everything except the target cannabinoid (typically THC). The distillation process produces a 85-95% pure THC oil that has been stripped of the minor cannabinoids, the terpenes, and the flavonoids. The result is a flavorless, high-potency oil that is ideal for vapes and edibles but lacks the full-spectrum profile of RSO. The medical and subjective difference between the two is the central RSO question, and the research literature on the entourage effect — while not definitive — supports the idea that full-spectrum products produce different effects than isolated THC at the same dose.

Typical Composition

The chemical composition of well-made RSO is consistent across producers. The major categories:

• Total THC: 50-80% by weight. The high THC content is what makes RSO a dose-respecting product. A 1g syringe at 70% THC contains 700mg of THC, which is enough for 14-28 standard doses for a tolerant patient.
• CBD: 0.5-3% for THC-dominant RSO. Higher-CBD formulations (1:1 or 1:2 THC:CBD) are produced by some operators and are the right choice for patients who want the CBD contribution for anxiety, inflammation, or seizure-related conditions.
• Minor cannabinoids: CBG (0.5-2%), CBN (0.2-1%), CBC, THCV, and others at trace levels. The full minor cannabinoid profile is what distinguishes RSO from distillate and is a meaningful contributor to the subjective effect.
• Terpenes: 2-6% total. The native terpene profile of the source flower is preserved through the ethanol wash, which produces a strong strain-specific aroma and contributes to the subjective effect.
• Plant lipids and waxes: 5-15%. The plant-derived fats and waxes are not removed in the ethanol wash, which is part of what gives RSO its thick consistency. Some operators winterize the crude oil to remove the lipids, which produces a cleaner product but loses some of the minor cannabinoids in the process.

Medical Uses: What the Research Actually Says

The medical evidence on RSO specifically is limited; most of the cannabis and chronic pain, sleep, and nausea research is on cannabis in general, not on the RSO format. The summary below covers what the research supports, what it suggests, and what is not supported at all.

Chronic Pain

There is reasonable evidence that full-spectrum cannabis products, including RSO, produce meaningful pain reduction for chronic neuropathic pain, chronic non-cancer pain, and pain associated with multiple sclerosis. A 2017 review by the National Academies of Sciences, Engineering, and Medicine concluded that cannabis and cannabinoids are effective for chronic pain in adults. The full-spectrum profile of RSO may be more effective than isolated THC for pain specifically, though the head-to-head research is limited.

Insomnia and Sleep Disorders

THC reliably reduces sleep onset latency (the time it takes to fall asleep) and increases total sleep time in the short term. The evidence is stronger for acute use than for chronic use, where tolerance develops. RSO's full-spectrum profile and the inclusion of sedating minor cannabinoids (CBN in particular) makes it a reasonable option for severe insomnia, especially at higher doses. For milder sleep issues, a low-dose edible or a CBN-forward formulation is a more appropriate entry point than full RSO.

Chemotherapy-Induced Nausea and Vomiting (CINV)

The evidence that cannabinoids reduce CINV is among the strongest in the cannabis literature. The FDA-approved dronabinol (Marinol) and nabilone (Cesamet) are synthetic THC formulations prescribed for this indication. RSO is a reasonable full-plant alternative for patients who do not respond to or tolerate the synthetic formulations. The dosing for CINV is typically 5-10mg of THC, 3-4 times per day during chemotherapy cycles, under medical supervision.

Multiple Sclerosis Spasticity

The evidence for cannabis and MS spasticity is moderate. Sativex (nabiximols), a 1:1 THC:CBD oromucosal spray, is approved in Canada, the UK, and most of Europe for MS spasticity, and the underlying research supports the conclusion that full-spectrum cannabis products reduce spasticity symptoms. RSO is a reasonable alternative for Maine MS patients who cannot access Sativex or who prefer a more flexible dosing format.

What RSO Does Not Treat

RSO is not a cure for cancer, multiple sclerosis, Crohn's disease, ALS, Parkinson's disease, Alzheimer's disease, or any other specific condition. The original Rick Simpson protocol promoted RSO as a cancer cure; the modern clinical evidence does not support that claim. Cannabis and cannabinoid products can be useful adjunctive therapies for cancer patients (for pain, nausea, appetite, and sleep), but they are not curative. Any source that claims RSO cures a specific disease is making a claim that the research does not support. Maine medical providers will not prescribe RSO as a curative therapy, and patients should be skeptical of any dispensary that markets RSO with curative claims.

Dose Protocol: Original Rick Simpson vs. Modern Clinical

The dosing protocol for RSO is the single most important part of using the product safely, and the difference between the original Rick Simpson protocol and the modern clinical guidance is significant.

The Original Rick Simpson Protocol

Rick Simpson's original protocol was aggressive: start at a rice-grain-sized dose (approximately 25-50mg of RSO, containing 15-30mg of THC), taken once daily for the first week, twice daily for the second week, three times daily for the third week, and increasing to four times daily by the fourth week. The protocol then recommended building to 1g of RSO per day (60-90 days total) — a target most modern practitioners consider excessively high. The original protocol was designed for a population of seriously ill patients willing to tolerate significant impairment, and it reflects a different era of clinical practice and patient expectation. The high-dose target is not consistent with the modern understanding of THC tolerance, dependence, and the risk of cannabinoid hyperemesis syndrome with chronic high-dose use.

Modern Clinical Dosing

The modern clinical consensus is to start low, titrate slowly, and target the minimum effective dose. For a first-time RSO user, the right starting dose is a rice-grain-sized amount once daily, with a 24-hour wait before the next dose. The reason for the 24-hour wait is that the full effect of a single RSO dose can take 12-24 hours to resolve, and stacking doses too quickly produces severe impairment and is the most common cause of negative RSO experiences.

After the initial 24-hour period, the dose can be increased to twice daily (morning and evening, separated by 8-10 hours) and held for 2-3 days. If the symptomatic relief is adequate, hold at that dose. If not, increase by a similar rice-grain increment and hold for another 2-3 days. The target dose for most chronic pain or insomnia patients is 0.5-1g of RSO per week, divided into 2-4 daily doses. This is a fraction of the original Rick Simpson target and reflects a more measured clinical approach.

Where to Buy Real RSO in Maine

RSO is sold at most licensed Maine dispensaries, and the operator list below covers the producers and retailers with the strongest RSO programs in the state. Pricing for a 1g syringe runs $40-80 depending on the operator and the potency. Medical patients pay 5.5% state sales tax only; adult-use customers pay the standard 15.5% combined tax.

Maine's Alternative Caring — Windham

Maine Craft Cannabis

The Maine Cannabis Company / Sola

Sinsemilla

Canuvo — Biddeford

Medical Caregivers

Registered Maine caregivers can grow for up to five medical patients each, and many caregivers produce their own RSO from their own flower. The caregiver RSO market is less standardized than the dispensary RSO market — every caregiver's RSO has a different potency, terpene profile, and price — but the price is typically 20-30% below dispensary retail and the patient-caregiver relationship allows for custom formulations and dosing adjustments. For a medical patient who has a stable relationship with a caregiver, the caregiver RSO is the highest-value option in the state. For a buyer new to RSO, start at a dispensary and consider the caregiver channel once you know what dose and formulation works. The Maine cannabis caregiver guide covers the caregiver program in detail.

Storage and Shelf Life

RSO is more shelf-stable than flower or rosin but less stable than distillate. The full-spectrum profile degrades over time with heat, light, and oxygen exposure. The storage protocol that keeps RSO at peak quality is straightforward:

• Refrigerator storage. RSO should be stored in a refrigerator at 35-40°F in the original syringe. Refrigerator storage slows the oxidation of the minor cannabinoids and preserves the terpene profile for 6-12 months.
• Upright, sealed. The syringe should be stored upright with the cap sealed to prevent air exposure. The plunger should not be depressed until use.
• Dark, not light. The original RSO packaging is typically opaque for light protection. If the syringe is in a clear container, transfer to an amber or opaque vessel.
• Shelf life: 6-12 months under refrigeration. After 12 months, the minor cannabinoid content will have degraded meaningfully even under ideal storage. Buy smaller syringes more frequently rather than stockpiling.

The RSO vs. Distillate Buyer-Beware Problem

The single biggest problem in the Maine RSO market is the mislabeling of distillate as RSO. The format is similar (both are sold in syringes), the price is comparable ($40-80 per gram), and the visual difference is not always obvious to a first-time buyer. The mislabeling is most common at adult-use dispensaries where the staff is less likely to be familiar with the visual and chemical differences. The way to protect yourself is straightforward and requires no special equipment:

1. Ask for the COA on the specific batch before purchase. Every licensed Maine dispensary must make COAs available. A real RSO COA shows 50-80% total THC, 1-3% CBD (or higher for 1:1 formulations), a meaningful CBG and CBN content, and 2-6% total terpenes. A distillate COA shows 85-95% THC, negligible minor cannabinoids, and 0-2% terpenes.
2. Look at the color and consistency. Real RSO is dark brown to black, with a thick, sticky consistency that holds its shape in the syringe. Distillate is lighter in color (amber to light brown) and more liquid. The visual difference is real.
3. Smell it. Real RSO has a strong cannabis aroma with a sharp solvent note (ethanol) that fades as the cure completes. Distillate with re-added terpenes has a sweeter, more confectionery aroma that does not match the source flower.
4. Check the price floor. Legitimate RSO cannot be sold for $20-30 per gram because the production cost is too high. A "RSO" priced significantly below the $40-80 market range is almost certainly distillate.

The mislabeling is not always intentional. Some producers use the term "RSO-style" to refer to a distillate cut with cannabis-derived terpenes, and the label can be confusing. The COA test is definitive; the visual and aroma tests are directional. For a Maine buyer who wants real RSO, the COA check is the price of admission.

RSO and the Medical Patient Framework

For Maine medical cannabis patients, RSO is one of the highest-value products in the dispensary catalog. The reasons are tax-related and dose-related. The Maine medical cannabis program (MMMP) exempts medical cannabis transactions from the 10% adult-use excise tax; medical patients pay only the 5.5% state sales tax. For a patient who purchases a 1g RSO syringe per month at $60 retail, the annual tax savings versus the adult-use channel is approximately $7-8 per syringe, or $84-96 per year. Modest per purchase, but real over time.

The dose-related advantage is more important. Medical patients have access to higher-dose RSO products (up to the 250mg per package medical limit) and to the RSO-infused capsule and edible formats that are not available at the adult-use counter. The MMMP card also provides access to medical-only dispensaries (Canuvo, Northeast Alliance, Maine Organic Therapy, American ReLeaf, and others) that specialize in the RSO and full-spectrum oil formats the medical market actually buys. For a patient who uses RSO regularly, the medical card pays for itself in 2-3 months through the tax savings alone. The Maine medical marijuana patient guide covers the application process, the qualifying conditions, and the MMMP reciprocity rules.